U.S. Marshals seize unapproved new drug from Crescendo Therapeutics LLC
date:May 23, 2012
professionals should notify the FDA of any problems associated with the product. Reports may be made to MedWatch, the FDA's voluntary reporting program, by calling 800-FDA-1088, or electronically at www.fda.gov/medwatch/report.htm.